Xylem Inc. XYL is witnessing strength in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. Growth in the transport application business, driven by the increased infrastructure projects in the United States, is boosting the Water Infrastructure segment’s performance. Recovery in the Applied Water segment, supported by higher demand for building solutions applications, also holds promise for the segment. Exiting first-quarter 2025, the company’s backlog totaled $5.1 billion, backed by strength across all regions. Strength in utilities, industrial and building solutions end markets is a key catalyst to the company’s growth. For 2025, Xylem expects revenues to be $8.7-$8.8 billion, indicating growth of 1-2% on a year-over-year basis. The company remains focused on acquiring businesses to gain access to new customers, regions and product lines. For instance, in December 2024, XYL completed the acquisition of a majority stake in Idrica. The inclusion of Idrica’s technology will offer growth opportunities for Xylem and enable it to penetrate new markets and deliver intelligent solutions to its customers. Also, in May 2023, XYL acquired Evoqua, a mission-critical water treatment solutions and services provider. Evoqua’s advanced water and wastewater treatment capabilities and exposure to key industrial markets complement Xylem’s portfolio of solutions across the water cycle. Acquisitions contributed $786 million to XYL’s total revenues in 2024. XYL remains committed to rewarding its shareholders through dividend payouts and share buybacks. In the first quarter of 2025, Xylem paid dividends of $98 million, reflecting an increase of 11.4% year over year. It repurchased shares worth $12.9 million in the same quarter. Also, in February 2025, the company hiked its dividend rate by 11%.Zacks Investment Research Image Source: Zacks Investment Research In the past six months, the Zacks Rank #3 (Hold) company has gained 4.7% compared with the industry’s 2.8% growth. Despite the positives, high debt levels are also likely to hurt Xylem’s profitability. It exited the first quarter with long-term debt of $1.97 billion. Also, considering its high debt level, its cash and cash equivalents of $1.06 billion do not look impressive. XYL has been grappling with rising operating costs and expenses. After witnessing a surge of 15.1% year over year in 2024, the company’s cost of revenues increased 1.6% in first-quarter 2025. Also, in 2024, its selling, general and administrative expenses surged 8.8% due to additional operational expenditure from the acquisition of Evoqua. Story Continues Key Picks Some better-ranked stocks from the same space are discussed below. Federal Signal Corporation FSS currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. FSS delivered a trailing four-quarter average earnings surprise of 6.4%. In the past 60 days, the Zacks Consensus Estimate for Federal Signal’s 2025 earnings has increased 1.3%. Unifirst Corporation UNF currently carries a Zacks Rank of 2. UNF delivered a trailing four-quarter average earnings surprise of 12.3%. In the past 60 days, the consensus estimate for Unifirst’s fiscal 2025 (ending August 2025) earnings has increased 4.1%. AptarGroup, Inc. ATR presently carries a Zacks Rank of 2. ATR delivered a trailing four-quarter average earnings surprise of 7.3%. In the past 60 days, the consensus estimate for AptarGroup’s 2025 earnings has increased 4.3%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unifirst Corporation (UNF):Free Stock Analysis Report AptarGroup, Inc. (ATR):Free Stock Analysis Report Federal Signal Corporation (FSS):Free Stock Analysis Report Xylem Inc. (XYL):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Here's Why Investors Should Consider Retaining Xylem Stock Now
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...